Skip to main navigation menu Skip to main content Skip to site footer

DISKORDANSI FENOTIPIK DAN GENOTIIK PADA BAKTERI PENGHASIL EXTENDED-SPECTRUM Β-LACTAMASE (ESBL): FENOMENA SILENT RESISTANT

Abstract

Extended-spectrum β-lactamase (ESBL) merupakan salah satu mekanisme resistensi antibiotik yang paling sering ditemukan pada Enterobacterales dan berkontribusi signifikan terhadap kegagalan terapi antibiotik β-laktam, khususnya sefalosporin generasi ketiga. Deteksi ESBL umumnya dilakukan melalui uji kepekaan antimikroba berbasis fenotipik, namun berbagai penelitian melaporkan adanya ketidaksesuaian antara hasil fenotipik dan keberadaan gen resistensi secara genotipik. Tinjauan literatur ini bertujuan untuk membahas fenomena diskordansi genotip–fenotip pada bakteri penghasil ESBL, termasuk keberadaan silent resistance, serta implikasinya terhadap diagnosis laboratorium dan pengelolaan klinis. Pencarian literatur dilakukan terhadap artikel ilmiah berbahasa Inggris yang diterbitkan pada periode 2020 hingga 2025 dan membahas resistensi β-laktam, ESBL, uji kepekaan antimikroba, serta hubungan antara profil genotipik dan fenotipik. Sejumlah sepuluh artikel yang memenuhi kriteria inklusi dianalisis dalam tinjauan ini. Hasil tinjauan menunjukkan bahwa sebagian isolat Enterobacterales yang membawa gen ESBL tetap menunjukkan hasil sensitif pada uji fenotipik, suatu kondisi yang berpotensi menyebabkan kesalahan interpretasi hasil laboratorium dan pemilihan terapi antibiotik yang kurang optimal. Selain itu, beberapa studi mengaitkan diskordansi ini dengan risiko kegagalan terapi dan luaran klinis yang tidak menguntungkan. Temuan ini menegaskan pentingnya pemahaman terhadap keterbatasan uji fenotipik dan perlunya pendekatan yang lebih komprehensif dalam menilai resistensi antibiotik pada infeksi akibat Enterobacterales penghasil ESBL.

Keywords

Extended-spectrum β-lactamase, diskordansi genotip–fenotip, uji kepekaan antimikroba, silent resistance

pdf

References

  1. 1. Amelia A, Nugroho A, Harijanto PN. Diagnosis and management of infections caused by Enterobacteriaceae producing extended-spectrum β-lactamase. Hospital. 2016;2.
  2. 2. Urmi UL, Nahar S, Rana M, Sultana F, Jahan N, Hossain B, et al. Genotypic to phenotypic resistance discrepancies identified involving β-lactamase genes, blakPC, blaIMP, blaNDM-1, and blaVIM in uropathogenic klebsiella pneumoniae. Infect Drug Resist. 2020;13:2863–75.
  3. 3. Rebelo AR, Bortolaia V, Leekitcharoenphon P, Hansen DS, Nielsen HL, Ellermann-Eriksen S, et al. One Day in Denmark: Comparison of Phenotypic and Genotypic Antimicrobial Susceptibility Testing in Bacterial Isolates From Clinical Settings. Front Microbiol. 2022 Jun 10;13.
  4. 4. Kime L, Randall CP, Banda FI, Coll F, Wright J, Richardson J, et al. Transient silencing of antibiotic resistance by mutation represents a significant potential source of unanticipated therapeutic failure. mBio. 2019;10(5).
  5. 5. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Vol. 372, BMJ. BMJ Publishing Group; 2021.
  6. 6. Lau CL, Neoh HM, Periyasamy P, Tg Abu Bakar Sidik TMI, Tan TL, Ramli R, et al. Prevalence and clinical significance of the genotypic carriage among ESBL phenotype-negative Escherichia coli and Klebsiella pneumoniae clinical isolates in bacteremia: a study in a Malaysian tertiary center. Front Cell Infect Microbiol. 2024;14.
  7. 7. Son T Van, Manh ND, Trung NT, Quyen DT, Meyer CG, Phuong NTK, et al. Molecular detection of bla CTX-M gene to predict phenotypic cephalosporin resistance and clinical outcome of Escherichia coli bloodstream infections in Vietnam. Ann Clin Microbiol Antimicrob. 2021 Dec 1;20(1).
  8. 8. Mushtaq A, Chasan R, Nowak MD, Rana M, Ilyas S, Paniz-Mondolfi AE, et al. Correlation between Identification of β-Lactamase Resistance Genes and Antimicrobial Susceptibility Profiles in Gram-Negative Bacteria: a Laboratory Data Analysis. Microbiol Spectr. 2022 Apr 27;10(2).
  9. 9. Abdelraouf K, Chavda KD, Satlin MJ, Jenkins SG, Kreiswirth BN, Nicolau DP. Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: Resistance Mechanisms and In vitro-In vivo Discordance. Int J Antimicrob Agents. 2020 Mar 1;55(3).
  10. 10. Emira AS, Madkour LAEF, Seif NE, Dwedar RA. Expressed and Silent Carbapenemase Genes Detected by Multiplex PCR in both Carbapenem-Resistant and Phenotypically-Susceptible Gram Negative Bacilli. Alexandria Journal of Medicine. 2020 Jan 1;56(1):181–8.
  11. 11. Davies TJ, Stoesser N, Sheppard AE, Abuoun M, Fowler P, Swann J, et al. Reconciling the potentially irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli. Antimicrob Agents Chemother. 2020 Jun 1;64(6).
  12. 12. Graf FE, Goodman RN, Gallichan S, Forrest S, Picton-Barlow E, Fraser AJ, et al. Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase-producing Enterobacterales. Nature Communications . 2024 Dec 1;15(1).
  13. 13. Golden AR, Karlowsky JA, Walkty A, Baxter MR, Denisuik AJ, Mccracken M, et al. Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18. Journal of Antimicrobial Chemotherapy. 2021 Nov 1;76(11):2825–32.
  14. 14. Kardjadj M, Priestly IP, Chavez R, Derrick D, Huard TK. Genotype–Phenotype Concordance and Ct-Informed Predictive Rules for Antimicrobial Resistance in Adult Patients with Complicated Urinary Tract Infections: Clinical and Stewardship Implications from the NCT06996301 Trial. Diagnostics. 2025 Nov 21;15(23):2945.

Similar Articles

51-60 of 110

You may also start an advanced similarity search for this article.